← All Twist Bioscience CORP filings

Twist Bioscience CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
TWST
Twist Bioscience CORP
DEF: Twist Bioscience Reports Strong FY25, Sets 2026 Meeting
Twist Bioscience Corporation announces robust fiscal year 2025 financial performance, including record revenue and improved gross margin, ahead of its 2026 Annual Meeting of Stockholders.
NASDAQ
TWST
Twist Bioscience CORP
DEF 14A: Twist Bioscience Seeks Stockholder Approval for Increased Share Authorization and Officer Exculpation
Twist Bioscience is asking stockholders to approve increasing the number of authorized shares and providing officer exculpation at the upcoming annual meeting.